Related references
Note: Only part of the references are listed.A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical applications
Josefine Schulz et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism
Josefine Schulz et al.
PHARMACEUTICS (2022)
Quantification of microdialysis related variability in humans: Clinical trial design recommendations
David Busse et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin
David Busse et al.
PHARMACEUTICAL RESEARCH (2021)
Simultaneous Retrodialysis by Drug for Cefuroxime Using Meropenem as an Internal Standard-A Microdialysis Validation Study
Pelle Hanberg et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2020)
Emerging Issues in Antifungal Resistance
John R. Perfect et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2020)
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Amir Arastehfar et al.
ANTIBIOTICS-BASEL (2020)
Invasive fungal disease in humans: are we aware of the real impact?
Carolina Firacative
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2020)
High voriconazole target-site exposure after approved sequence dosing due to nonlinear pharmacokinetics assessed by long-term microdialysis
Claudia Kirbs et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children
A. Warris et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism
Josefine Schulz et al.
DRUG METABOLISM REVIEWS (2019)
Antifungal drugs: What brings the future?
Ruth Van Daele et al.
MEDICAL MYCOLOGY (2019)
Drug combinations and impact of experimental conditions on relative recovery in in vitro microdialysis investigations
Daniela Burau et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens
Daniel Z. P. Friedman et al.
JOURNAL OF FUNGI (2019)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Simultaneous Retrodialysis by Calibrator for Rapid In Vivo Recovery Determination in Target Site Microdialysis
Yichao Yu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Matthew C. Fisher et al.
SCIENCE (2018)
Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients
Iris K. Minichmayr et al.
CLINICAL PHARMACOKINETICS (2017)
lmerTest Package: Tests in Linear Mixed Effects Models
Alexandra Kuznetsova et al.
JOURNAL OF STATISTICAL SOFTWARE (2017)
The global problem of antifungal resistance: prevalence, mechanisms, and management
David S. Perlin et al.
LANCET INFECTIOUS DISEASES (2017)
Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections
Issam S. Hamadeh et al.
PHARMACOGENETICS AND GENOMICS (2017)
Effects of cytochrome P450 3A4 and non-genetic factors on initial voriconazole serum trough concentrations in hematological patients with different cytochrome P450 2C19 genotypes
Beibei Shao et al.
XENOBIOTICA (2017)
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Felix Bongomin et al.
JOURNAL OF FUNGI (2017)
Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics
Nicolas Hohmann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Microdialysis as an Important Technique in Systems Pharmacology-a Historical and Methodological Review
Margareta Hammarlund-Udenaes
AAPS JOURNAL (2017)
Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis
Xiaofei Li et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections
Fabien Lamoureux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
A retrospective analysis of patient-specific factors on voriconazole clearance
Satoshi Dote et al.
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2016)
Variability of Voriconazole Plasma Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Cytochrome P450 Polymorphisms and Comedications on Initial and Subsequent Trough Levels
Elodie Gautier-Veyret et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A
K. Ona et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Fitting Linear Mixed-Effects Models Using lme4
Douglas Bates et al.
JOURNAL OF STATISTICAL SOFTWARE (2015)
Tissue Penetration of Antifungal Agents
Timothy Felton et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Population pharmacokinetics meets microdialysis: Benefits, pitfalls and necessities of new analysis approaches for human microdialysis data
Andre Schaeftlein et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
In vitro microdialysis recovery and delivery investigation of cytokines as prerequisite for potential biomarker profiling
Claudia Kirbs et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections
Taotao Wang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype
Dimitrios Zonios et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?
Aniwaa Owusu Obeng et al.
PHARMACOTHERAPY (2014)
Pilot Investigation on Long-Term Subcutaneous Microdialysis: Proof of Principle in Humans
Franziska Simmel et al.
AAPS JOURNAL (2013)
A Multistep Voriconazole-Related Phototoxic Pathway May Lead to Skin Carcinoma: Results From a French Nationwide Study
Olivier Epaulard et al.
CLINICAL INFECTIOUS DISEASES (2013)
Steady-state pharmacokinetics and metabolism of voriconazole in patients
Marcus J. P. Geist et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents
Keith A. Rodvold et al.
CLINICAL PHARMACOKINETICS (2011)
Microdialysis feasibility investigations with the non-hydrophilic antifungal voriconazole for potential applications in nonclinical and clinical settings
F. Simmel et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Phototoxicity and photocarcinogenesis associated with voriconazole
O. Epaulard et al.
MEDECINE ET MALADIES INFECTIEUSES (2011)
Pharmacogenomics of the triazole antifungal agent voriconazole
Gerd Mikus et al.
PHARMACOGENOMICS (2011)
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
Ina Scholz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Tissue concentrations: do we ever learn?
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?
Ursula Theuretzbacher
CURRENT OPINION IN PHARMACOLOGY (2007)
Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes
Norie Murayama et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis
Cornelia Buerger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Microdialysis - theoretical background and recent implementation in applied life-sciences
N Plock et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Quantitative in vivo microdialysis in pharmacokinetic studies:: Some reminders
MJ Cano-Cebrián et al.
CURRENT DRUG METABOLISM (2005)
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents:: Distribution in tissue
M Müller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human
SJ Roffey et al.
DRUG METABOLISM AND DISPOSITION (2003)
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
R Hyland et al.
DRUG METABOLISM AND DISPOSITION (2003)
Share Paper
